オハイオにおける炎症性腸疾患の臨床試験
オハイオ内の拠点で、炎症性腸疾患に関する16件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
- UH Minoff Health Center, Chagrin Falls
- University Hospitals Cleveland Medical Center, Cleveland
- UH Westlake Health Center, Westlake
被験者募集中健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07852273A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- GCGA Physicians, LLC dba / Gastro Health Research, Cincinnati
- NexGen Research, Lima
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Beavercreek
被験者募集中第1/2相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT06619990A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-025, Brunswick
- Site US-023, Dayton
- Site US-027, Westlake
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07845487Non-nutritive Sweeteners in Inflammatory Bowel Disease
- UH Minoff Health Center, Chagrin Falls
- University Hospitals Cleveland Medical Center, Cleveland
- UH Westlake Health Center, Westlake
被験者募集中健康なボランティア歓迎
18歳〜70歳 · 全性別 · 2026/09/25更新 · NCT07769437Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345Study of DISC-0974-201 in Participants With IBD and Anemia
- Gastro Health - Cincinnati, Cincinnati
- Gastro Health - Blue Ash Care Center, Cincinnati
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07368972Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Cleveland Clinic Foundation, Cleveland
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/21更新 · NCT07513181A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中第4相
3 Weeks · 女性 · 2026/09/08更新 · NCT07612267A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Childrens Medical Center, Dayton
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/24更新 · NCT05509777Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Cincinnati, Cincinnati
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/05更新 · NCT07237516Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
- UH/Rainbow Babies and Children's Hospital, Cleveland
- Nationwide Children's Hospital, Columbus
被験者募集中第4相
6歳〜17歳 · 全性別 · 2026/05/27更新 · NCT05781152ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Gastro Intestinal Research Institute of Northern Ohio,, Westlake
被験者募集中観察研究健康なボランティア歓迎
22歳以上 · 全性別 · 2026/04/28更新 · NCT06810518A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Cincinnati
- Mirador Therapeutics Selected Site, Liberty Township
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522Evaluation of the SMART IBD App in Pediatric IBD
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中
13歳〜17歳 · 全性別 · 2025/11/21更新 · NCT07195123Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- University of Cincinnati, Cincinnati
被験者募集中観察研究
18歳以上 · 全性別 · 2025/05/08更新 · NCT06750731ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。